LEADERSHIP PAGE
Executive Team
Board of Directors
Dan Adams, JD
Chairman,
EVA Therapeutics
Annie De Groot, MD
President, Treasurer and Founder,
EVA Therapeutics
CEO/CSO EpiVax Inc.
1998-2026
Richard Lipkin, MBA
Managing Director,
Easton Capital;
Co-founder,
The Catalytic Impact Foundation
Lenny Moise, PhD
Member of the Board,
EVA Therapeutics
PARTNERS
Scientific Advisors
Aurelio Bonavia, PhD
Clinical Virology Consultant, Merck
Industry expert specializing in vaccines and monoclonal antibodies.
Dominique Bridon, PhD
CEO, Diaccurate
Peptide technology expert with over 35 years of experience
Manon Cox, PhD, MBA
CEO, NextWaveBio
Scientific and strategic direction
Daniel F. Hoft, MD, PhD
Professor & Director of the Division of Infectious Diseases, Allergy and Immunology, Saint Louis University School of Medicine
Nationally recognized physician-scientist in the field of vaccines and immunotherapies.
Wayne C. Koff, PhD
Managing Partner, Next Frontier Advisors
Expert in international vaccine and immunotherapeutic R&D dedicated to global health.
Judy Lieberman, MD, PHD
Professor & Chair Immunology, Harvard Medical School
Accomplished immunology expert
Eleanor Ramos, MD
CMO/COO, Provention Bio
Clinical development and medical affairs specialist
Takuya Tsunoda, MD, PhD
Specially Appointed Professor of Medical Oncology & Director of the Comprehensive Cancer Information Center, Showa Medical University
Cancer immunotherapy pioneer, with both industry and academic experience
Dr. Sandhya Vasan, MD
Chief Medical and Science Officer & Senior VP of Global Infectious Diseases Research, Henry M. Jackson Foundation
Experienced clinical and preclinical research leader in infectious diseases.
